VAISHALI PHARMA LIMITED
Latest filings
- Preferential shares of 45.37 lakh listed on NSE, under lock-in till April 2027 · Capital Market Events
- Routine demat compliance certificate filed for Q2 FY26 · Compliance
- Trading window closure for Q2 and half-year results · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE, reporting revenue of ₹108 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Not enough history to assess.Charts
How has the market priced it — with filings on the timeline?
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from VAISHALI PHARMA LIMITED's filed financials and exchange disclosures
What does VAISHALI PHARMA LIMITED do?
VAISHALI PHARMA LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE, trading under the symbol VAISHALI.
Is VAISHALI PHARMA LIMITED profitable?
Yes. Over the trailing twelve months VAISHALI PHARMA LIMITED reported a net profit of ₹4.43 Cr on revenue of ₹108 Cr.
Is VAISHALI PHARMA LIMITED debt-free?
No. It reported borrowings of ₹19 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹17 Cr after cash. Debt stands at 0.27× equity. That is higher than 65% of its 166 Pharmaceuticals peers.
Is VAISHALI PHARMA LIMITED expensive compared with its peers?
On trailing P/E, VAISHALI PHARMA LIMITED ranks 47 of 158 in Pharmaceuticals — cheaper than 70% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the VAISHALI PHARMA LIMITED share price move in a day?
On a typical session VAISHALI PHARMA LIMITED moves 1.28% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track VAISHALI PHARMA LIMITED's announcements?
Every NSE and BSE filing by VAISHALI PHARMA LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.